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ABSTR AC T

Background and study aims After stone removal in
endoscopic retrograde cholangiopancreatography (ERCP),

Introduction
Gallstone disease affects over 20 million Americans [1]. Among
patients with gallbladder disease, prevalence of choledocholithiasis is estimated to be 10 % to 20 % [2, 3] Endoscopic retrograde cholangiopancreatography (ERCP) is considered the
standard of care for removing stones in the bile duct utilizing a
variety of conventional methods including biliary sphincterotomy, balloon dilation, extraction balloon, retrieval basket, and
lithotripsy. After removal of stones from the bile duct, a balloon
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an occlusion cholangiogram (OC) is performed to confirm
bile duct clearance. OC can miss residual stones that can
lead to recurrent biliary symptoms. The aim of this study
was to assess if digital peroral cholangioscopy (POC) increased the diagnostic yield of residual biliary stones that
are missed with OC.
Patients and methods Patients having ERCP performed
for choledocholithiasis were enrolled into the study only if
they had one of the following criteria: dilated bile duct
≥ 12 mm and/or if lithotripsy was being performed. An OC
was performed to confirm duct clearance after removal of
stones followed by POC, based on inclusion criteria. The incremental yield of biliary stones missed by OC but confirmed by POC was then measured. A total of 96 POC procedures were performed on 93 patients in two tertiary care
centers.
Results Residual biliary stones were found in 34 % of
cases. The average bile duct size in cases with residual
stones was 15.1 mm ± 0.7 mm. One- to three-mm stones
were found in 41 % of cases, 4- to 7-mm stones in 45 % of
cases, and ≥ 8-mm stones in 14 % of cases. Lithotripsy was
performed in 13 % of cases and was significantly associated
with residual stones (30 % vs. 3 %, P < 0.001).
Conclusions Occlusion cholangiogram can miss residual
stones in patients with dilated bile ducts and those receiving lithotripsy. Digital POC can increase the yield of residual stone detection in these patients and should be considered to confirm clearance of stones. (ClinicalTrials.govNCT03482375).

occlusion cholangiogram is usually performed to confirm complete bile duct clearance. However, occlusion cholangiogram
(OC) can miss residual stones in 11 % to 30 % of cases, especially
in the setting of a dilated bile duct, severe pneumobilia, and
after lithotripsy (mechanical, electrohydraulic, or laser) [4 – 8].
Missed bile duct stones can lead to recurrent biliary symptoms,
pancreatitis, cholangitis, and can have significant cost implication with the need for repeat imaging and/or procedures [4].
Peroral cholangioscopy (POC) enables direct visualization of
the bile duct and allows for diagnostic and therapeutic maneu-
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Patients and methods
Patients
This was a prospective tandem study conducted at two large
academic tertiary care hospitals that are part of Northwell
Health System (Long Island, New York, United States). The
study was approved by the Northwell Health Institutional Review Board and all patients signed informed consent prior to
participating. All patients were scheduled for standard-of-care
endoscopy. Inclusion criteria were suspected or documented
choledocholithiasis and: 1) dilated bile duct ≥ 12 mm (any portion of duct); and/or 2) the patient underwent mechanical lithotripsy (ML) or electrohydraulic lithotripsy (EHL) for therapy
of bile duct stones. Patients younger than age 18 years or who
had altered anatomy including Billroth II, Roux-en-Y Gastric bypass, and Whipple procedure were excluded.

Procedure
All ERCPs were performed under general anesthesia per the institutional standard of care. Five therapeutic endoscopists with
formal training in advanced endoscopy performed the procedures (DS, AT, CL, LM, and PB). All procedures were performed
with a Philips Veradius fluoroscopy C-arm with flat detector.
Standard-of-care ERCP was performed with cannulation of the
bile duct and cholangiogram to identify any biliary stones. If
stones were identified, they were removed with conventional
methods such as sphincterotomy, balloon extraction, basket retrieval, and/or lithotripsy. It is our standard practice to sweep
the bile duct several times with a balloon prior to OC to remove
any residual stones. After the endoscopist thought the bile duct
was cleared, an OC was performed with the balloon size being
determined by the duct diameter. The concentration of contrast was left to the discretion of the individual endoscopist’s
standard of care. If the OC was negative, and if patient met enrollment criteria, digital POC (SpyGlass DS, Boston Scientific,

Marlborough, Massachusetts, United States) was performed to
assess for residual stones. All operators are experienced in cholangioscopy and have performed at least 30 exams prior to initiation of the study. The single-use disposable cholangioscope
was then inserted under endoscopic and fluoroscopic guidance
over a wire just proximal to the bile duct hilum. The catheter is
10.5 Fr in diameter, has a four-way tip control, (the catheter
handle includes two control knobs for left-right and up-down
tip deflection), two channels for water infusion and suction,
and a single 1.2-mm working channel. After adequate visualization of the bile duct was achieved, the scope was slowly pulled
back carefully examining the entire bile duct. The endoscopists
were instructed to examine the right and left hepatic ducts, the
hilum, the common hepatic duct, the common bile duct, and
the cystic duct/stump takeoff.
Any residual stones that were documented by POC were removed or treated, such as with stone extraction, lithotripsy, or
stent placement. All patients that received POC were given one
dose of intravenous antibiotic during the procedure because of
the associated risk of bacteremia [13].
The primary aim of this study was to determine the incremental yield of digital POC in detection of residual biliary
stones that were not detected on an OC. Patients with residual
stones detected on POC after OC were defined as the positive
POC group. Patients without residual stones on POC after OC
were defined as the negative POC group.

Statistical analysis
Based on the literature, it is estimated that between 11 % and
30 % of these patients will have stones identified on POC that
were missed by conventional ECRP. If the percent of patients
with missed stones is 30 %, then the 95 % exact binomial confidence intervals for the proposed sample size of 100 subjects
is 21.2 % to 40.0 %. Due to the expected screen failure rate
(eg: – Bile duct size < 12 mm etc.) of approximately 30 % to 40 %,
we planned to enroll a total of 140 subjects.
Continuous variables were expressed as a mean (± Standard
Error). Statistical comparisons between them were performed
using an unpaired Student’s t-test. Categorical variables were
expressed as percentages. Comparisons between nominal variables were performed using the chi-squared test. When two
variables were dichotomous, Fisher’s exact test was used.
When % of expected count less than five, is more than 25 %,
then Phi and Cramer’s V was used. A P value < 0.05 was considered statistically significant.
All calculations were made using the SPSS 22 statistical
package (SPSS Inc., Chicago, Illinois, United States).

Results
From January 2016 to February 2018, 140 patients with suspected or documented choledocholithiasis were enrolled into
the study, of which 93 patients met inclusion criteria of dilated
bile duct ≥ 12 and/or lithotripsy being performed. Analysis was
performed on a total of 96 procedures from the 93 patients. Patient characteristics are listed in ▶ Table 1. Three patients had
repeat procedures because biliary stents were placed after de-
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vers. Although POC has been available for over 30 years, it did
not become a widespread technique due to the fact that traditional cholangioscopes are fragile, cumbersome to use, and require two endoscopists to perform the procedure. Introduction
of a single-operator semi-disposable, fiberoptic cholangioscope system (SpyGlass, Boston Scientific, Marlborough, Massachusetts, United States) addressed many of the concerns
associated with traditional cholangioscopes and led to more
widespread use of cholangioscopy [5, 9, 10]; however, the suboptimal image quality limited its application. Recent introduction of a completely disposable digital version of the Spyglass
system has significantly improved image quality, thus augmenting the diagnostic and therapeutic capabilities of cholangioscopy [11, 12].
Given the substantial miss rate of residual stones on OC, it
has been proposed that digital POC may be beneficial for detecting residual stones, especially in the setting of a dilated
bile duct or lithotripsy. The goal of this prospective study was
to assess whether digital POC would increase the diagnostic
yield of residual biliary stones that are missed with OC during
conventional ERCP.

Original article

▶ Table 1 Demographics and patient characteristics.
Total qualified

Negative POC

Positive POC

P value

procedures

Positive POC

P value

with stones
≥ 4 mm

Ethnicity

96 (100 %)

63 (66 %)

33 (34 %)

Age

65.1 ± 1.7

64.2 ± 2.3

66.9 ± 2.6

0.47

66.5 ± 3.6

0.61

Male

33 (34 %)

19 (30 %)

14 (42 %)

0.23

9 (45 %)

0.22

Female

63 (66 %)

44 (70 %)

19 (58 %)

Hispanic

17 (18 %)

14 (23 %)

3 (9 %)

Non-Hispanic

67 (71 %)

41 (66 %)

26 (79 %)

17 (85 %)

Not reported

11 (12 %)

7 (11 %)

4 (12 %)

3 (15 %)

27.7 ± 0.7

27.6 ± 0.8

27.7 ± 1.1

BMI
Inclusion
criteria

Bile duct size ≥ 12 mm
only

20 (21 %)

11 (55 %)
0.26

0 (0 %)

0.96

29.2 ± 1.4

0.33

1

13 (65 %)

0.006 1

84 (88 %)

61 (97 %)

23 (70 %)

2 (2 %)

0 (0 %)

2 (6 %)

0.048 1

2 (10 %)

0.011 1

10 (10 %)

2 (3 %)

8 (24 %)

0.001 1

5 (25 %)

0.08

History of cholecystectomy

44 (46 %)

28 (44 %)

16 (49 %)

0.71

11 (55 %)

0.41

Past treatment

ERCP

64 (67 %)

39 (62 %)

25 (76 %)

0.17

15 (75 %)

0.29

Balloon extraction

37 (39 %)

25 (40 %)

12 (36 %)

0.75

6 (30 %)

0.44

Lithotripsy

13 (14 %)

6 (10 %)

7 (21 %)

0.11

5 (25 %)

0.08

Sphincterotomy

26 (27 %)

17 (27 %)

9 (27 %)

0.98

4 (20 %)

0.53

Balloon dilation

7 (7 %)

4 (6 %)

3 (9 %)

0.63

1 (5 %)

0.83

Basket retrieval

3 (3 %)

3 (5 %)

0 (0 %)

0.11

0 (0 %)

0.32

47 (49 %)

27 (43 %)

20 (61 %)

0.09

12 (60 %)

0.18

Other

3 (3 %)

1 (2 %)

2 (6 %)

0.25

1 (5 %)

0.39

Total bilirubin

2.8 ± 0.4

2.4 ± 0.4

3.4 ± 0.9

0.26

3.7 ± 0.7

0.12

Direct bilirubin

2.1 ± 0.3

2.2 ± 0.5

1.8 ± 0.4

0.53

1.9 ± 0.5

0.70

Indirect bilirubin

1.2 ± 0.2

1.4 ± 0.3

1.1 ± 0.2

0.75

1.3 ± 0.17

0.97

Lithotripsy only
Both bile duct size ≥
12mm and had lithotripsy

Biliary stent

LABS

Patient
location

< 0.001

0.07

293 ± 39.8

0.03 1

0.53

180.7 ± 37.9

0.95

144.3 ± 33.5

0.74

118.5 ± 27.1

0.42

23 (37 %)

10 (30 %)

0.51

7 (35 %)

0.87

39 (63 %)

23 (70 %)

Alkaline phosphatase

221.3 ± 17.6

196 ± 20.6

270.3 ± 31.7

0.04

ALT

187.1 ± 20.5

177.9 ± 21.6

205.3 ± 43.8

AST

154.2 ± 20.9

159.2 ± 26.1

Inpatient

33 (35 %)

Outpatient

62 (65 %)

1

13 (65 %)

ALT, alanine aminotransferase; AST, aspartate aminotransferase.
P values are based on comparing to patients with negative POC.
1
Significant

tection and/or lithotripsy of stones; these patients met inclusion criteria on their subsequent ERCP.
The main indication for performing POC was presence of a
dilated bile duct ≥ 12 mm (88 %), followed by a combination of
dilated bile duct ≥ 12 mm and lithotripsy (10 %), and lithotripsy
only (2 %). Thirty-four percent of the cases had residual stones
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seen on POC (▶ Table 2, ▶ Fig. 1, ▶ Fig. 2). In patients with positive POC, the average total number of stones was 1.6 + /– 0.1
with most stones seen in the common bile duct (67 %), followed
by hilum (15 %), cystic stump (12 %) and common hepatic duct
(6 %). Average stone size was 4.2 mm + /– 0.3 mm, median 4.0,
range 1 – 10 mm. One- to 3-mm stones were found in 41 % of
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Gender

Count

▶ Table 2 POC characteristics/findings in patients with residual stones.

Common hepatic duct

1 (5 %)

22 (67 %)

13 (65 %)

Hilum

5 (15 %)

3 (15 %)

Cystic stump

4 (12 %)

3 (15 %)

Average number of stones per patient

1.6 ± 0.1

1.6 ± 0.2

4.2 ± 0.3
(Range 1 to 10)
(Median 4)

5.6 ± 0.3
(Range 4 to 10)
(Median 5)

Stone size 1 to 3 mm

21 (41 %)

___________

Stone size 4 to 7 mm

23 (45 %)

23 (77 %)

Stone size ≥ 8 mm

7 (14 %)

7 (23 %)

Balloon extraction

24 (73 %)

15 (75 %)

Biliary stent placement

8 (24 %)

4 (20 %)

Lithotripsy

6 (18 %)

4 (20 %)

▪ Mechanical

0 (0 %)

0 (0 %)

▪ EHL

6 (18 %)

4 (20 %)

Sphincterotomy

1 (3 %)

1 (5 %)

Balloon dilatation

2 (6 %)

1 (5 %)

Basket retrieval

0 (0 %)

0 (0 %)

Other

1 (3 %)

1 (5 %)

Average stone size (mm)

Treatment after POC

≥ 4 mm (N = 20)

2 (6 %)

Common bile duct

Grouping based on stone sizes

Positive POC with stones

N = 33 cases (34 %)

EHL, electrohydraulic lithotripsy

cases, 4- to 7-mm stones in 45 % of cases, and ≥ 8-mm stones in
14 % of cases.
The average bile duct size in the positive and negative POC
groups was not statistically different (15.1 ± 0.7, range 11 – 30
mm and 14.3 ± 0.2, range 12 – 20 mm; P = 0.2) (▶ Table 3).
When evaluating bile duct sizes (ranging from 11 – 30 mm), no
one size was statistically associated with residual stones. Average stone size initially seen on ERCP prior to POC was significantly larger in the POC-positive group vs. the POC-negative
group (9.6 mm ± 0.9 mm vs. 6.7 mm ± 0.4 mm, P = .001). When
evaluating stone shapes, cuboidal stones were significantly
associated with the positive POC group (30 % vs. 12 %, P =
0.003). Lithotripsy (both EHL and ML) was performed in 13 % of
cases and was significantly associated with the positive POC
group (30 % vs. 3 %, P < 0.001). A subgroup analysis of patients
with stones ≥ 4 mm in the positive POC group was also performed and compared to the negative POC group ( ▶ Table 1,
▶ Table 2, ▶ Table 3); the findings were similar as all patients
with residual stones except that the percentage of cuboidal
stones was less.
There were a total of three adverse events (AEs) that were
related to the procedure. In the positive POC group, one patient
had cholangitis which was classified as “mild” based on Ameri-

can Society of Gastrointestinal Endoscopy guidelines on AEs
associated with ERCP (the patient was admitted and discharged
the next day with PO antibiotics for 7 days). In the negative POC
group, two patients had “moderate” pancreatitis, which was
classified based on consensus definition and classification proposed by Cotton et al [14, 15].

Discussion
ERCP cholangiogram is considered the reference standard for
diagnosis of choledocholithiasis. In fact, most studies evaluating EUS and magnetic resonance cholangiopancreatography
for detection of choledocholithiasis use ERCP cholangiogram
or intraoperative cholangiography as the “gold standard” for
presence or absence of biliary stones [16 – 23]. However, ERCP
cholangiogram and intraoperative cholangiography have been
reported to miss stones, especially in the setting of a dilated
bile duct or when lithotripsy is performed [6, 24, 25]. Thus,
ERCP cholangiogram may not be sensitive enough to confirm
clearance of the bile duct in these settings.
Peroral cholangioscopy provides direct visualization of the
bile duct during ERCP and its benefits are well documented in
numerous published studies. POC is most commonly per-
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Location of stones

Positive POC

▶ Fig. 2 Digital cholangioscopy showing a residual stone that was
found within the cystic stump.

▶ Fig. 1 a Negative occlusion cholangiogram in a dilated bile duct
after removal of multiple stones. b Digital cholangioscopy showing
a 6-mm residual stone in the common bile duct.

formed for management of difficult biliary stones and for evaluation of biliary strictures [11]. However, POC has also been described in evaluation of residual stones that are missed with
cholangiogram. In a multicenter study evaluating POC for a
variety of indications, 11 % of patients (7/66) had bile duct
stones identified only by POC that were missed on ERCP [5]. In
a study of patients with primary sclerosing cholangitis, 30 % of
patients (7/23) were found to have stones with POC that were
missed with cholangiography [26]. Lee et al. analyzed a group
of 64 patients that had undergone mechanical lithotripsy and
found that 28.3 % (13/46) had residual stones seen with POC
that were missed with an OC [7]. Itoi et al. assessed residual
bile duct stones found with POC in comparison to balloon cholangiography in a retrospective study of 108 patients; they
found that 24 % of patients (26/108) had residual stones seen
with POC that were missed with balloon-occluded cholangiography [6]. The residual stones ranged in size from 2 to 8 mm
with a mean of 4.8 mm. The authors found that frequency of

E612

missed stones was significantly higher with large stone size,
presence of juxtapapillary diverticulum, and when ML or EHL
was performed. In a small prospective study of 22 patients,
Haung et al. showed that 22.7 % (5/22) had residual stones detected with POC after a negative balloon-occluded cholangiography [27]. Because of the small sample size, no statistical analysis was performed. However, the residual stones ranged from
2 to 5 mm with a mean bile duct diameter of 19 mm in these patients.
Our study is the largest prospective study to date that evaluated digital POC in detecting residual stones in dilated bile
ducts and/or lithotripsy patients that are missed with conventional ERCP. In our study, 34 % of cases were found to have residual stones that were seen on POC but missed with an OC.
Large stone size (> 9 mm), cuboidal stones, and lithotripsy
were all significantly associated with residual stones. The average bile duct size in cases with residual stones was 15.1 mm ±
0.7 mm. We attempted to clarify patients by degree of bile
duct dilation (e. g. > 15 mm), but found no correlation with residual stones. However, our sample size was not powered to find
a relationship between specific duct size and residual stones.
In 12 % of the positive POC cases, residual stones were found
in or at the cystic stump in post-cholecystectomy patients. POC
may potentially play an important role in detection of residual
stones in the setting of a dilated cystic stump, especially when
there is a low take-off from the bile duct. Presumably, these
stones can ball-valve in and out of the cystic stump into the
main bile duct and cause recurrent symptoms.
The strengths of this study include the prospective tandem
design, large sample size for this type of study, and inclusion
of multiple endoscopists that increases the generalizability of
our study. The main limitation of the study is that we cannot
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▶ Table 3 ERCP procedure characteristics.
Total qua-

Negative

Positive

lified pro-

POC

POC

P value

3 (5 %)

1 (3 %)

0.69

1 (3 %)

0.97

48 (50 %)

27 (43 %)

21 (64 %)

0.05 1

13 (65 %)

0.08

Average

14.5 ± 0.3

14.3 ± 0.2

15.1 ± 0.7

0.2

15.5 ± 1.1

0.13

Median

14

14

15

14

Range

11 – 30

12 – 20

11 – 30

11 – 30

≥ 15 mm

44 %

40 %

52 %

0.27

≥ 18 mm

9%

10 %

9%

0.95

Stone size (mm)

Average

Stone shapes

Round

Treatment during ERCP

7.6 ± 0.4
70 (40 %)

6.7 ± 0.4
44 (40 %)

9.6 ± 0.9
26 (39 %)

0.001
0.84

Cuboidal

33 (19 %)

13 (12 %)

20 (30 %)

0.003

Ovoid

63 (36 %)

43 (40 %)

20 (30 %)

0.12

Other

10 (6 %)

9 (8 %)

1 (2 %)

0.06

Balloon extraction
Biliary stent placement
Lithotripsy
▪ Mechanical

93 (97 %)
6 (6 %)

63 (100 %)
2 (3 %)

30 (91 %)

0.015

4 (12 %)

0.08

12 (13 %)

2 (3 %)

10 (30 %)

2 (3 %) 2

1 (2 %)

1 (3 %) 2

1

< 0.001

1

1

1

0.64

40 %

0.98

15 %

0.49

8.9 ± 1.2

0.02 1

16 (53 %)

0.20

4 (13 %)

0.84

9 (30 %)

0.34

1 (3 %)

0.36

18 (90 %)

0.011 1

3 (15 %)

0.07

6 (30 %)

< 0.001 1

1 (5 %)

0.39

6 (30 %)

< 0.001 1

▪ EHL

11 (11 %)

1 (2 %)

10 (30 %)

Sphincterotomy

37 (39 %)

28 (44 %)

9 (27 %)

0.10

5 (25 %)

0.12

Balloon dilatation

16 (17 %)

8 (13 %)

8 (24 %)

0.15

5 (25 %)

0.19

Basket retrieval

2 (2 %)

1 (2 %)

1 (3 %)

0.65

0 (0 %)

0.57

Other

1 (1 %)

0 (0 %)

1 (3 %)

0.17

0 (0 %)

______

2

< 0.001

1

P values are based on comparing to patients with negative POC.
EHL, electrohydraulic lithotripsy; ERCP, endoscopic retrograde cholangiopancreatography
1
Significant
2
One patient had both mechanical lithotripsy and EHL

determine the clinical significance of missed residual stones.
While there is no definitive way to know if the residual stones
would be symptomatic if not detected and removed, we
grouped the residual stones into categories based on their size
and potential clinical relevance; 1- to 3-mm stones were seen in
41 % of cases, 4- to 7-mm stones were seen in 45 % of cases, and
8-mm and greater stones were seen in 14 % of cases. In general,
59 % of stones seen on POC were 4 mm or greater and 23 % of
these were ≥ 8 mm. We believe that these larger stones may
have more clinical significance. The patients with stones
≥ 4 mm on POC were subdivided and compared to the negative
POC group to identify risk factors for having larger residual
stones; however, the findings were similar to all patients with
residual stones. Some studies that have analyzed risk factors
for recurrent biliary stones suggest that even small residual

stone fragments might act as nidi for future stone formation
and lead to recurrent stones [28 – 31].
Another limitation of the study is that it was not blinded as
the same operator performed the OC and the subsequent POC.
In addition, no cost analysis was performed; we did not address
the direct cost of POC for detection of residual stones nor did
we address potential cost savings from avoidance of repeat procedures or hospitalizations from residual stones. Also, the additional potential risk of performing POC on top of standard-ofcare ERCP was not addressed in this study.
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≥ 4 mm

4 (4 %)

Biliary stent present
at time of index ERCP
Bile duct size (mm)

P value

with stones

cedures
Juxtapapillary
diverticulum

Positive POC

Original article

In conclusion, OC can miss residual stones in patients with dilated bile ducts and those receiving lithotripsy. Digital POC can
increase the yield of residual stone detection in these patients
and should be considered to confirm clearance of stones.
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